A-to-I RNA editing;
ADAR enzymes;
Human cancers;
SARCOMA-ASSOCIATED HERPESVIRUS;
PROSTATE-CANCER;
HUMAN TRANSCRIPTOME;
HUMAN GLIOBLASTOMA;
BLADDER-CANCER;
MESSENGER-RNA;
BREAST-CANCER;
EDITED RNAS;
HUMAN BRAIN;
GENE;
D O I:
10.1016/j.semcdb.2011.09.003
中图分类号:
Q2 [细胞生物学];
学科分类号:
071009 ;
090102 ;
摘要:
Carcinogenesis is a complex, multi-stage process depending on both endogenous and exogenous factors. In the past years, DNA mutations provided important clues to the comprehension of the molecular pathways involved in numerous cancers. Recently, post-transcriptional modification events, such as RNA editing, are emerging as new players in several human diseases, including tumours. A-to-I RNA editing changes the nucleotide sequence of target RNAs, introducing A-to-I/G "mutations". Since ADAR enzymes catalyse this nucleotide conversion, their expression/activity is essential and finely regulated in normal cells. This review summarizes the available knowledge on A-to-I RNA editing in the cancer field, giving a new view on how ADARs may play a role in carcinogenesis. (C) 2011 Elsevier Ltd. All rights reserved.
机构:
Western Gen Hosp, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, ScotlandOsped Pediat Bambino Gesu Res Inst, Angiogenesis, I-00165 Rome, Italy
机构:
Western Gen Hosp, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, ScotlandOsped Pediat Bambino Gesu Res Inst, Angiogenesis, I-00165 Rome, Italy